Physiology of ageing
"aging" AND "physiology" AND "cellular mechanisms"
physiology of ageing age-related changes organ systems

This composite educational graphic illustrates the Ageing-Related Distribution of Ageing (ARDA) in lateral cephalometric radiography (LCR). Panel A displays an anatomical diagram of a lateral skull radiograph with color-coded regions-of-interest (instances), including the eye socket, maxilla, mandibular bone, and cervical vertebrae C1-C5. Panel B presents a 3D quantitative distribution chart plotting age (4-40 years) against specific anatomical instances and quantified ARDA values. The three stacked surface plots represent different ageing-significant region thresholds (median, 75th, and 90th percentiles), showing how salience concentrated in local regions as subjects aged. Panel C provides a multi-frame heatmap progression, mapping average ageing salience across different ages. A central large LCR image of a 28-year-old subject shows the heatmap overlay, where a blue-to-red color gradient indicates low-to-high ageing salience. High salience is notably concentrated in the temporal bone and teeth regions. This visualization demonstrates that human development information is widely distributed across the craniofacial structure in early childhood, while ageing markers become localized in specific dental and skeletal regions after age 12.

This educational image consists of two side-by-side axial brain CT slices (a and b) demonstrating the challenges of automated cerebral infarct detection in elderly patients. Figure (a) is a processed grayscale CT slice showing the brain parenchyma with visible age-related changes. A red square on the right hemisphere (anatomical left) highlights a deepened sulcus, labeled as a 'false positive' and 'a sulcus due to ageing.' The area appears as a dark, hypodense linear feature representing cerebrospinal fluid-filled spaces common in brain atrophy. Figure (b) displays the corresponding t-score map, where the same sulcular region is represented by high-intensity (bright white) pixels within a red square. This high t-score indicates a significant statistical deviation from a younger control group template, leading to an erroneous identification of an infarct. The image illustrates the clinical relevance of age-matched control groups in neuroradiological diagnostic algorithms to prevent false positives caused by normal age-related structural evolution such as cortical atrophy and sulcal widening.

This composite educational graphic presents an Average Relative Distribution of Ageing (ARDA) salience map of the cervical spine across a developmental timeline from 4 to 40 years. The central focus is a lateral cephalometric radiographic (LCR) image of a 28-year-old subject overlaid with a color-coded heat map (blue to red gradient) indicating ageing-significant regions. The surrounding grid displays 37 individual heat maps representing the progression of ageing salience for each year of age. In early childhood (ages 4–9), the salience is broadly and diffusely distributed, reflecting rapid growth and developmental changes. As maturation occurs, particularly after age 12, the ageing salience becomes more localized and consistent. Red and dark red zones indicate high intensity salience, primarily concentrated in the vertebral bodies and the spinous processes of the C2–C5 vertebrae. Anatomical landmarks include the vertebral bodies C1 through C5. This visualization is used in forensic medicine and skeletal maturity assessment to identify specific regions of the cervical spine that provide diagnostic information for biological age estimation and physiological development tracking.

This medical schematic illustrates the longitudinal lifecycle of brain myelination across the human lifespan. The primary element is a line graph plotting myelination levels against age in years. The trajectory shows a rapid increase during early childhood, childhood, and adolescence, plateauing in adulthood and peaking around age 40-50. This is followed by a steady decline in the 'ageing' phase, labeled as a 'global decrease in white matter volume during normal ageing' (solid black line). A diverging dashed red line indicates a more rapid, 'accelerated loss of myelin in neurodegeneration' occurring after age 60. Annotations identify the 'average age of onset of multiple neurodegenerative diseases' coinciding with the start of the physiological decline. Accompanying sagittal brain illustrations visualize the 'progression of myelination' in early life with centrifugal blue arrows and 'Alzheimer’s disease pathological changes' in late life with red arrows indicating cortical destruction. This diagram serves as an educational tool for understanding white matter dynamics in neurology and geriatrics.
| Term | Meaning |
|---|---|
| Gerontology | Study of physical and psychological changes of old age |
| Geriatrics | Clinical care of the aged |
| Senescence | Lowering of biological efficiency accompanying ageing |
| Biological age | Not identical to chronological age |
| Normal Physiological Change | Associated Pathology |
|---|---|
| Decreased arterial elasticity | Atherosclerosis |
| Elevated afterload | Coronary artery disease |
| Elevated systolic blood pressure | Essential hypertension |
| Left ventricular hypertrophy | Congestive heart failure |
| Decreased adrenergic activity | Cardiac arrhythmias |
| Decreased resting heart rate | Aortic stenosis |
| Decreased maximal heart rate | - |
| Decreased baroreceptor reflex | - |
| Normal Physiological Change | Associated Pathology |
|---|---|
| Decreased pulmonary elasticity | Emphysema |
| Decreased alveolar surface area | Chronic bronchitis |
| Increased residual volume | Pneumonia |
| Increased closing capacity | - |
| Ventilation/perfusion (V/Q) mismatching | - |
| Decreased arterial oxygen tension (PaO2) | - |
| Increased chest wall rigidity | - |
| Decreased respiratory muscle strength | - |
| Decreased cough reflex | - |
| Blunted response to hypercapnia and hypoxia | - |
| Normal Physiological Change | Associated Pathology |
|---|---|
| Decreased renal blood flow | Diabetic nephropathy |
| Decreased renal plasma flow | Hypertensive nephropathy |
| Decreased GFR | Prostatic obstruction |
| Decreased renal mass | Congestive heart failure |
| Decreased tubular function | - |
| Impaired sodium handling | - |
| Decreased concentrating ability | - |
| Decreased diluting capacity | - |
| Decreased renin-aldosterone responsiveness | - |
| Impaired potassium excretion | - |

| Parameter | Change with Ageing | Clinical Effect |
|---|---|---|
| Body composition | Reduced lean mass, increased fat% | Higher Vd for lipophilic drugs; prolonged effect |
| Plasma albumin | Reduced | More free (active) drug for protein-bound agents |
| Renal clearance | Reduced GFR | Drug accumulation - reduce doses |
| Hepatic clearance | Reduced | Prolonged half-life for hepatically metabolised drugs |
| CNS sensitivity | Increased | Lower doses of sedatives/opioids needed |